VERVE THERAPEUTICS INC (VERV) Forecast, Price Target & Analyst Ratings

NASDAQ:VERV • US92539P1012

Current stock price

11.13 USD
+0.03 (+0.27%)
At close:
11.2 USD
+0.07 (+0.63%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VERVE THERAPEUTICS INC (VERV).

Forecast Snapshot

Consensus Price Target

Price Target
$13.26
+ 19.14% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 7, 2025
Period
Q2 / 2025
EPS Estimate
-$0.72
Revenue Estimate
4.777M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
71.43%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$13.26
Upside
+ 19.14%
From current price of $11.13 to mean target of $13.26, Based on 14 analyst forecasts
Low
$11.11
Median
$13.52
High
$15.75

Price Target Revisions

1 Month
-7.69%
3 Months
-51.55%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for VERV. The average price target is 13.26 USD. This implies a price increase of 19.14% is expected in the next year compared to the current price of 11.13.
The average price target has been revised downward by 51.55% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

VERV Current Analyst RatingVERV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

VERV Historical Analyst RatingsVERV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
71.43%
VERV was analyzed by 14 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about VERV.
In the last month the buy percentage fell by 13 points. So the trust of analysts is decreasing.
VERV was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-06-27BMO CapitalDowngrade Outperform -> Market Perform
2025-06-18LifeSci CapitalDowngrade Outperform -> Market Perform
2025-06-18JefferiesDowngrade Buy -> Hold
2025-06-18HC Wainwright & Co.Downgrade Buy -> Neutral
2025-06-17William BlairDowngrade Outperform -> Market Perform
2025-06-17Canaccord GenuityDowngrade Buy -> Hold
2025-04-15Cantor FitzgeraldUpgrade Neutral -> Overweight
2025-04-15GuggenheimMaintains Buy -> Buy
2025-04-15Canaccord GenuityMaintains Buy -> Buy
2025-04-14HC Wainwright & Co.Maintains Buy -> Buy
2025-03-25GuggenheimReiterate Buy -> Buy
2025-03-25HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-04RBC CapitalMaintains Outperform -> Outperform
2025-02-28HC Wainwright & Co.Maintains Buy -> Buy
2024-11-06RBC CapitalMaintains Outperform -> Outperform
2024-11-06Canaccord GenuityMaintains Buy -> Buy
2024-11-06HC Wainwright & Co.Maintains Buy -> Buy
2024-08-12Canaccord GenuityMaintains Buy -> Buy
2024-08-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-09RBC CapitalMaintains Outperform -> Outperform
2024-05-09HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-03StifelMaintains Buy -> Buy
2024-02-28RBC CapitalReiterate Outperform -> Outperform
2023-09-13Cantor FitzgeraldReiterate Neutral -> Neutral
2023-08-29Cantor FitzgeraldReiterate Neutral -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 7, 2025
Period
Q2 / 2025
EPS Estimate
-$0.72
Revenue Estimate
4.777M
Revenue Q2Q
-28.62%
EPS Q2Q
-21.59%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
3.49%
Revenue (3 Months)
-2.15%
EPS (1 Month)
-0.12%
EPS (3 Months)
-2.43%

Next Earnings Summary

VERV is expected to report earnings on 8/7/2025. The consensus EPS estimate for the next earnings is -0.72 USD and the consensus revenue estimate is 4.78M USD.
The next earnings revenue estimate has been revised downward by 2.15% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
VERV revenue by date.VERV revenue by date.
1.94M11.758M
506.08%		32.332M
174.98%		47.068M
45.58%		20.556M
-56.33%		17.748M
-13.66%		21.42M
20.69%		25.364M
18.41%		90.61M
257.24%		265.71M
193.25%		544.17M
104.80%
EBITDA
YoY % growth
VERV ebitda by date.VERV ebitda by date.
-162.89M
-90.45%		-217.669M
-33.63%		-221.907M
-1.95%		-272.449M
-22.78%		-342.242M
-25.62%		-377.782M
-10.38%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
VERV ebit by date.VERV ebit by date.
-165.69M
-90.30%		-223.124M
-34.66%		-228.66M
-2.48%		-254.313M
-11.22%		-299.307M
-17.69%		-345.988M
-15.60%		-367.914M
-6.34%		-430.202M
-16.93%		-394.706M
8.25%		-155.04M
60.72%		79.56M
151.32%
Operating Margin
VERV operating margin by date.VERV operating margin by date.
-8,540.72%-1,897.64%-707.23%-540.31%-1,456.06%-1,949.45%-1,717.62%-1,696.11%-435.61%-58.35%14.62%
EPS
YoY % growth
VERV eps by date.VERV eps by date.
-2.92
38.44%		-3.12
-6.85%		-2.35
24.68%		-2.54
-8.20%		-3.00
-18.11%		-2.77
7.79%		-2.99
-7.80%		-3.23
-8.08%		-3.00
6.95%		-1.74
41.90%		1.00
157.31%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth		-0.72
-21.59%		-0.74
-25.63%		-0.74
-27.50%		-0.71
-104.00%
Revenue
Q2Q % growth		4.777M
-28.62%		4.376M
-36.26%		4.306M
-67.08%		8.211M
-75.10%
EBITDA
Q2Q % growth		-72.42M
-30.39%		-74.46M
-43.59%		-75.48M
-53.06%		N/A
EBIT
Q2Q % growth		-69.611M
-18.31%		-72.426M
-27.26%		-72.841M
-29.92%		-71.359M
-94.78%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VERV Yearly Revenue VS EstimatesVERV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
VERV Yearly EPS VS EstimatesVERV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1 -2 -3 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-5.63%
EPS Next 5 Year
-6.55%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-9.91%
Revenue Next 5 Year
0.88%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-16.21%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

VERVE THERAPEUTICS INC / VERV Forecast FAQ

Can you provide the average price target for VERVE THERAPEUTICS INC stock?

14 analysts have analysed VERV and the average price target is 13.26 USD. This implies a price increase of 19.14% is expected in the next year compared to the current price of 11.13.

When does VERVE THERAPEUTICS INC (VERV) report earnings?

VERVE THERAPEUTICS INC (VERV) will report earnings on 2025-08-07, before the market open.

Can you provide the consensus estimates for VERVE THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of VERVE THERAPEUTICS INC (VERV) is -0.72 USD and the consensus revenue estimate is 4.78M USD.

How many analysts have analysed VERVE THERAPEUTICS INC (VERV)?

The number of analysts covering VERVE THERAPEUTICS INC (VERV) is 14.